biological interpretation of deepomicsae output using metaboanalyst

गहरी शिक्षा के साथ अल्जाइमर रोग में सिग्नलिंग मॉड्यूल का विश्लेषण

An increasingly large proportion of the population is aging and the burden of age-related diseases, such as neurodegeneration, is expected to sharply increase in the coming decades1. Alzheimer&#39;s disease is the most common type of neurodegenerative disease2. Progress in finding a treatment has been slow given our poor understanding of the fundamental&#160;molecular mechanisms driving the onset and progress of the disease. The majority of information on Alzheimer&#39;s disease is gained postmortem from the examination of brain tissue, which has made distinguishing causes and consequences a difficult task3. The Religious Orders Study/Memory and Aging Project (ROSMAP) is an ambitious effort to gain a broader understanding of neurodegeneration, which involves the study of thousands of individuals who have committed to undergo medical and psychological examinations yearly and to contribute their brains for research after their demise4. The study focuses on the transition from the normal functioning of the brain to Alzheimer&#39;s disease2. Within the project, postmortem brain samples&#160;were analyzed with a plethora of omics approaches, including genomics, epigenomics, transcriptomics, proteomics5, and metabolomics.
Omics technologies that offer functional readouts of cellular states (i.e., proteomics and metabolomics)6,7 are key to interpreting disease8,9,10,11,12, due to the direct relationship between protein and metabolite abundance and cellular activities. Proteins are the primary executors of cellular processes, while metabolites are the substrates and products for biochemical reactions. Multi-omics data analysis offers the possibility to understand the complex relationships between proteomics and metabolomics data instead of appreciating them in isolation. Multi-omics is a discipline that studies multiple layers of high-dimensional biological data, including molecular data (genome sequence and mutations, transcriptome, proteome, metabolome), clinical imaging data, and clinical features. Particularly, multi-omics data analysis aims to integrate such layers of biological data, understand their reciprocal regulation and interaction dynamics, and deliver a holistic understanding of disease onset and progression. However, methods to integrate multi-omics data remain in the early stages of development13.
Autoencoders, a type of unsupervised neural network14, are a powerful tool for multi-omics data integration. Unlike supervised neural networks, autoencoders do not map samples to specific target values (such as healthy or diseased), nor are they used to predict outcomes. One of their primary applications&#160;lies in dimensionality reduction. However, autoencoders offer several advantages over simpler dimensionality reduction methods such as principal component analysis (PCA), t-distributed stochastic neighbor embedding (tSNE), or uniform manifold approximation and projection (UMAP). Unlike PCA, autoencoders can capture non-linear relationships within the data. Unlike tSNE and UMAP, they can detect hierarchical and multi-modal relationships within the data since they rely on multiple layers of computational units each containing non linear activation functions. Therefore, they represent attractive models to capture the complexity of multi-omics data. Finally, while the primary application of PCA, tSNE, and UMAP is that of clustering the data, autoencoders compress the input data into extracted features that are well-suited for downstream predictive tasks15,16.
Briefly, neural networks comprise several layers, each containing multiple computational units or &#34;neurons.&#34; The first and last layers are referred to as the input and output layers, respectively. Autoencoders are neural networks with an hourglass structure, consisting of an input layer, followed by one to three hidden layers and a small &#34;latent&#34; layer typically containing between two and six neurons. This structure&#39;s first half is known as the encoder and is combined with a decoder mirroring the encoder. The decoder ends with an output layer containing the same number of neurons as the input layer. Autoencoders take the input through the bottleneck and reconstruct it in the output layer, with the goal of generating an output that mirrors the original information as closely as possible. This is achieved by mathematically minimizing a parameter termed &#34;reconstruction loss.&#34; The input consists of a set of features, which in the application showcased herein will be protein and metabolite abundances, and clinical characteristics (i.e., sex, education, and age at death). The latent layer contains a compressed and information-rich representation of the input, which can be used for subsequent applications such as predictive models17,18.
This protocol presents a workflow, DeepOmicsAE, which involves: 1) preprocessing of proteomics, metabolomics, and clinical data (i.e., normalization, scaling, outlier removal) to obtain data with a consistent scale for machine learning analysis; 2) selecting appropriate autoencoder input features, since feature overload may obscure relevant disease patterns; 3) optimizing and training the autoencoder, including determining the optimal number of proteins and metabolites to select, and of neurons for the latent layer; 4) extracting features from the latent layer; and 5) utilizing the extracted features for biological interpretation by identifying molecular signaling modules and their relationship with clinical features.
This protocol aims to be simple and applicable by&#160;biologists with limited computational experience who have a basic understanding of programming with Python. The protocol focuses on analyzing multi-omics data, including proteomics, metabolomics, and clinical features, but its use can be extended to other types of molecular expression data, including transcriptomics. One important novel application introduced by this protocol is mapping the importance scores of original features onto individual neurons in the latent layer. As a result, each neuron in the latent layer represents a signaling module, detailing the interactions between specific molecular alterations and the patients&#39; clinical characteristics. Biological interpretation of the molecular signaling modules is obtained by using MetaboAnalyst, a publicly available tool that integrates gene/protein and metabolite data to derive enriched metabolic and cell signaling pathways17.

लेखक स्पॉटलाइट: अल्जाइमर अनुसंधान को आगे बढ़ाना - प्रारंभिक पहचान और मल्टी-ओमिक्स दृष्टिकोण की खोज

DeepOmicsAE: प्रोटिओमिक्स, मेटाबोलॉमिक्स और क्लिनिकल डेटा के गहन शिक्षण विश्लेषण के साथ अल्जाइमर रोग में सिग्नलिंग मॉड्यूल का प्रतिनिधित्व करना

Alzheimer's disease is thought to initiate decades before symptoms emerge. Recent studies suggest that phenotypic traits such as obesity and hypertension, but also the level of education and social engagement can act as risk factors. Our goal is to become able to decipher their contributions and their relation to molecular drivers of disease to learn how to intervene early and in a personalized manner.Multi-omic data analysis can be used for integrating various layers of biological data such as proteomics, transcriptomics, metabolomics, and phenotypic traits to comprehensively understand a disease state. Autoencoder models use deep learning to reduce the dimensionality of multi-omics datasets, effectively summarizing the crucial information, However, it is challenging to interpret how important are individual features in the original data with respect to the summarized output. In Deep-omics AE, we built in an algorithm that derives the importance of individual multi-omics features relative to the learn reduced dimensionality representation.With this approach, we can identify molecularly similar modules and their association with patient's phenotypic traits. Deep-omics AE helps putting in relation patient's phenotypic traits with the molecular makeup of disease. For example, you can use it to ask, what are the molecular pathways that are most implicated in Alzheimer's disease in older patients, and what are those that are most implicated in younger patients?What are those implicated in developing the disease in less educated patients versus more educated patients?

MetaboAnalyst का उपयोग कर DeepOmicsAE आउटपुट की जैविक व्याख्या

शुरू करने के लिए, एक वेब ब्राउज़र खोलें और मेटाबोएनालिस्ट वेबसाइट पर संयुक्त मार्ग विश्लेषण कार्यक्षमता तक पहुंचने के लिए लिंक पर नेविगेट करें। उस फ़ोल्डर तक पहुँचें जहाँ DeepOmicsAE को लागू करने से आउटपुट फ़ाइलें सहेजी जाती हैं, और उत्पन्न प्रत्येक सिग्नलिंग मॉड्यूल के लिए module_n. txt नाम की टेक्स्ट फ़ाइलें खोलें।पाठ फ़ाइलों से, प्रोटीन की सूची का पता लगाएं और उन्हें कॉपी करें। मेटाबोएनालिस्ट वेबपेज पर, वैकल्पिक गुना परिवर्तन विंडो के साथ जीन के प्रोटीन में प्रोटीन की कॉपी की गई सूची पेस्ट करें। चयापचयों के लिए दोहराएँ, उन्हें एक ही वेबपेज पर वैकल्पिक गुना परिवर्तन खिड़की के साथ यौगिक सूची में चिपका.प्रासंगिक जीव और आईडी प्रकार चुनें। फिर, पेज के निचले भाग में सबमिट करें पर क्लिक करके जानकारी सबमिट करें. अगले पृष्ठ पर, यह सुनिश्चित करने के लिए ID मैपिंग सत्यापित करें कि पहचानकर्ताओं की सही पहचान की गई है और फिर आगे बढ़ें पर क्लिक करें.पैरामीटर सेटिंग पृष्ठ में, मेटाबोलिक पथ एकीकृत या सभी पथ एकीकृत या सभी पथ मेटाबोलिक या सभी सिग्नलिंग मार्गों में इनपुट के योगदान की कल्पना करने के लिए एकीकृत सभी मार्गों का चयन करें। एल्गोरिथ्म चयन पैनल में, संवर्धन विश्लेषण, हाइपरजियोमेट्रिक टेस्ट चुनें; टोपोलॉजी उपाय, डिग्री केंद्रीयता; और एकीकरण विधि, पी मानों को मार्ग-स्तर को मिलाएं। पृष्ठ के नीचे सबमिट पर क्लिक करें।अंतिम पृष्ठ, परिणाम दृश्य, संवर्धन विश्लेषण के परिणामों को प्रदर्शित करेगा। इसमें उनके प्रभाव और महत्व के आधार पर समृद्ध मार्गों के भूखंड और मार्गों की एक सारणीबद्ध सूची शामिल है। स्वस्थ या अल्जाइमर रोगियों के मस्तिष्क के नमूनों से डेटासेट पर डीपओमिक्सएई पर प्राप्त सिग्नलिंग मॉड्यूल की मेटाबोएनालिस्ट व्याख्या से पता चला है कि प्रत्येक सिग्नलिंग मॉड्यूल के लिए, अलग-अलग चयापचय और सिग्नलिंग मार्ग समृद्ध थे।इसके अलावा, नैदानिक सुविधाओं और सिग्नलिंग मॉड्यूल के बीच होने वाली बातचीत के लक्षण वर्णन से पता चला है कि अल्जाइमर रोगियों में परिवर्तित ग्लिसरॉलिपिड चयापचय मृत्यु के समय उनके लिंग और उम्र से जुड़ा था। इसके विपरीत, अल्जाइमर रोगियों में सिनैप्स और अक्षतंतु कार्यक्षमता में परिवर्तन होते हैं, चाहे उनका लिंग, शिक्षा स्तर और दीर्घायु कुछ भी हो।

Research

JoVE Journal

Biology

Biological Interpretation of DeepOmicsAE Output Using MetaboAnalyst

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Large omics datasets are becoming increasingly available for research into human health. This paper presents DeepOmicsAE, a workflow optimized for the ...

Data Preprocessing for DeepOmicsAE Workflow

DeepOmicsAE वर्कफ़्लो के लिए डेटा प्रीप्रोसेसिंग

Optimizing Model Parameters and Implementing DeepOmicsAE Workflow

मॉडल पैरामीटर का अनुकूलन और DeepOmicsAE वर्कफ़्लो को लागू करना